Pd11-07 Integrated Results of Two Multicenter, Randomized, Placebo Controlled, Double Blind, Phase 3 Trials (Spi-611/612) of Single-Dose Intravesical Apaziquone Immediately Following Resection in Patients With Non-Muscle Invasive Bladder Cancer
Journal of Urology - Netherlands
doi 10.1016/j.juro.2016.02.847
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)